| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.167 | 22.830 | 25.077 | 31.244 | 36.174 | 51.617 | 25.989 | 0 | 0 | 0 |
| Total Income - EUR | 22.181 | 22.832 | 26.010 | 31.245 | 36.596 | 51.627 | 26.001 | 8 | 1 | 0 |
| Total Expenses - EUR | 17.138 | 14.688 | 14.253 | 22.813 | 29.115 | 19.337 | 12.917 | 6.109 | 240 | 2.628 |
| Gross Profit/Loss - EUR | 5.043 | 8.144 | 11.757 | 8.432 | 7.482 | 32.290 | 13.085 | -6.101 | -239 | -2.628 |
| Net Profit/Loss - EUR | 4.378 | 7.688 | 11.506 | 8.119 | 7.115 | 31.963 | 12.838 | -6.101 | -239 | -2.628 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Diagnose S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.917 | 3.537 | 3.792 | 27.787 | 20.351 | 14.619 | 10.287 | 6.450 | 6.430 | 0 |
| Current Assets | 5.995 | 5.779 | 8.127 | 6.125 | 11.209 | 30.267 | 15.904 | 2.752 | 191 | 120 |
| Inventories | 0 | 0 | 1.136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.916 | 3.226 | 3.085 | 2.916 | 3.414 | 21.021 | 97 | 0 | 0 | 0 |
| Cash | 3.079 | 2.553 | 3.907 | 3.209 | 7.796 | 9.245 | 15.807 | 2.752 | 191 | 120 |
| Shareholders Funds | 9.388 | 8.050 | 11.671 | 14.214 | 15.996 | 32.005 | 18.602 | 6.475 | 6.217 | -282 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 523 | 1.266 | 249 | 19.699 | 15.565 | 12.880 | 7.590 | 2.726 | 404 | 402 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Diagnose S.r.l.